Pat McKeough

A professional investment analyst for more than 30 years, Pat has developed a stock-selection technique that has proven reliable in both bull and bear markets. His proprietary ValuVesting System™ focuses on stocks that provide exceptional quality at relatively low prices. Many savvy investors and industry leaders consider it the most powerful stock-picking method ever created.

As early as 1980, Pat was recognized as #1 in the world of published investment advice by the Washington, DC–based Newsletter Publishers Association, and he was the first multi-year winner of The Globe and Mail’s stock picking contest.

Both CBS MarketWatch and The Hulbert Financial Digest recognized Pat as one of North America’s top stock analysts. The Wall Street Journal called him “one of only four investment newsletter advisors who have managed to serve their readers well over the long haul.”

A best-selling Canadian author, he wrote Riding the Bull, his 1993 book that predicted the stock-market boom of the last half of that decade. Through his many television appearances, he is well-known to investors for his insightful analysis and his candid, unpretentious style.

Bottom line: Pat’s conservative, reduced-risk strategy is a proven approach to safe investing.

Posts by the author
ETF investing is one of the best financial innovations of our time but themed ETF investing—including the Dogs of the Dow — is a poor investing strategy
Aggressive and conservative investors alike must assess a range of the risks when they consider how much to invest in stocks for their investment portfolios
Fortuna Mining Corp. is a cash-rich gold producer with three operating mines now aiming to boost output
REITs Canada is the remaining category of income trusts, continue to pay distributions before they pay tax—and that’s good for unitholders.
RRSP meltdown strategies promise to save you tax on withdrawals, but we view them as a risky strategy better for brokers than investors.
You can develop your own diversified investment portfolio by spreading your holdings out over the main economic sectors, looking for high-quality companies and more
Northrop Grumman Corp. reports steady results as it continues to win new orders.
Some Canadian investors use currency hedging to protect against a future drop in the U.S. dollar. Consider the iShares Core S&P 500 ETF.
The pandemic presented both of these firms with unique challenges. However, each remained profitable and is now well positioned to keep prospering. Trends underway as well as the strong position of each firm in its key markets will power future gains. Both of these leaders are buys.


ALCON, $79.26, is a buy. The firm (New York symbol ALC; TSINetwork Rating: Average) (www.alcon.com; Shares outstanding: 491.2 million; Market cap: $38.6 billion; Dividend yield 0.4%) is the world’s biggest eye-care company. Specifically, it’s the leader in ocular surgical supplies and No. 2 in contact lenses.